PROT#C1073-415: An Open Label Extension Study of the Efficacy and Safety of CORLUX (mifepristone) in the Treatment of the Signs and Symptoms of Endogenous Cushing's Syndrome

Project: Research project

Project Details

StatusFinished
Effective start/end date7/10/09 → 7/10/12

Funding

  • Corcept Therapeutics Incorporated (C1073-415)